Clinical Trials Update: Dec. 30, 2003

Hepatitis High Cholesterol (Hyperlipidemia) Menopause

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Hepatitis

People ages 18-65 who have hepatitis may qualify to participate in a clinical research study of a 9-week evaluation of hepatitis C patients using the combination of ribavirin and peg-interferon alfa-2a. Research site located in Orlando, Fla.

More Information

Please see http://www.centerwatch.com/patient/studies/cat79.html.

-----

High Cholesterol (Hyperlipidemia)

A study to evaluate the efficacy and safety of rosuvastatin and atorvastatin in the treatment of hypercholesterolemia in Hispanic subjects. Hispanic participants age 18 and older with high cholesterol may be eligible. Research site located in Golden, Colo.

More Information

Please see http://www.centerwatch.com/patient/studies/cat170.html.

-----

Menopause

Understanding the role that hot flashes and sleep disruption play in the effect of estrogen replacement therapy on mood in perimenopausal women. Perimenopausal woman aged 40-58 with frequent hot flashes, sleeplessness, and mood swings may be eligible. Research site located in Boston, Mass.

More Information

Please see http://www.centerwatch.com/patient/studies/cat181.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com